NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...
Indeed, the Not This Again host reflected on her two experiences with getting Botox, and how her latest injections left her face extremely tight. “If you’re wondering, ‘Bobbi, why can’t your face move ...